Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study.
Saved in:
| Title: | Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study. |
|---|---|
| Authors: | Stahl, Andreas1 (AUTHOR) andreas.stahl@med.uni-greifswald.de, Bründer, Marie‐Christine1 (AUTHOR), Lagrèze, Wolf A.2 (AUTHOR), Molnár, Fanni E.2 (AUTHOR), Barth, Teresa3 (AUTHOR), Eter, Nicole4 (AUTHOR), Guthoff, Rainer5 (AUTHOR), Krohne, Tim U.6 (AUTHOR), Pfeil, Johanna M.1 (AUTHOR), Bühler, Anima (AUTHOR), Daniel, Moritz (AUTHOR), Felzmann, Susanne (AUTHOR), Gross, Nikolai (AUTHOR), Horn, Stefanie (AUTHOR), Müller, Claudia (AUTHOR), Reichl, Sabine (AUTHOR), Reiff, Charlotte (AUTHOR), Richter, Olga (AUTHOR), Stech, Milena (AUTHOR), Hentschel, Roland (AUTHOR) |
| Source: | Acta Ophthalmologica (1755375X). Feb2022, Vol. 100 Issue 1, pe91-e99. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
